Search

everythinglearnresearchcommunity

for

Search:↓

Most children with skin inflammation taking methotrexate had lab abnormalities, but liver issues often improved without changing the medication dose.

Dupilumab may help treat alopecia areata without needing high IgE levels.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

Abrocitinib effectively treats severe alopecia areata with significant improvement and no side effects.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

Microneedles show promise for cancer diagnosis and treatment due to their minimally invasive nature and effective drug delivery.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

M30 is a promising treatment for preventing hair loss during chemotherapy.

Ritlecitinib is an effective new treatment for Alopecia Areata.

Careful monitoring is crucial to prevent JC virus reactivation in lupus patients treated with rituximab.

Microneedle patches with different pore sizes can effectively deliver drugs and trigger strong immune responses.

CMC2.24 and CMC2.23 reduce melanin safely and effectively.

Ciproterone acetate improves hair regrowth and acne in most female patients.

New methods to improve the healing abilities of mesenchymal stem cells for disease treatment are promising but need more research.

Alefacept does not effectively treat severe alopecia areata.

M50054 may help treat hepatitis and hair loss from chemotherapy.

Adding dupilumab led to almost complete hair regrowth in a patient with alopecia areata who only partially responded to baricitinib.

Mimosine dipeptides are promising for treating hyperpigmentation and inflammation.

Frunevetmab injections in cats can cause severe itching and skin lesions.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

TAK-279 effectively reduces psoriasis symptoms and is safe.

A young woman with a rare skin cancer was diagnosed late because her symptoms were unusual for the disease.

The treatment was ineffective in humans.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Etanercept effectively treated a severe skin condition when other treatments failed.

Patients with metastatic breast cancer treated with epirubicin and docetaxel had a good response and maintained their quality of life.

The topical treatment WR 279,396 effectively healed cutaneous leishmaniasis in mice without relapse.